Skip to main content

Day: November 26, 2024

SUNation Energy to Participate in Bank of America Clean Energy Symposium

RONKONKOMA, N.Y., Nov. 26, 2024 (GLOBE NEWSWIRE) — SUNation Energy, Inc. (Nasdaq: SUNE) (“SUNation” or the “Company”), a leading provider of sustainable solar energy and backup power to households, businesses, municipalities, and for servicing existing systems, today announced that Scott Maskin, Interim CEO, and Jim Brennan, COO will participate in the Bank of America Clean Energy Symposium.    Management is scheduled to participate in the Democratizing Solar: Tapping into the Untapped US Residential Market panel discussion on Thursday, December 5, 2024 at 11:00 AM ET. Management will also host investor meetings in person on December 5, 2024, and virtually on December 6, 2024. Interested investors should contact their Bank of America sales representative. About SUNation Energy, Inc.SUNation Energy, Inc. is focused on growing leading...

Continue reading

Cannabix Technologies Receives Positive Testing Certification for Breath Logix Autonomous Alcohol Breathalyzer

Cannabix has developed an autonomous alcohol breathalyzer screening device for employers and a range of industries and safety settings VANCOUVER, British Columbia, Nov. 26, 2024 (GLOBE NEWSWIRE) — Cannabix Technologies Inc. (CSE: BLO) (OTC PINK: BLOZF) (Frankfurt: 8CT) (the “Company or Cannabix”) developer of marijuana and alcohol breath testing devices is pleased to report that it has received a positive certification test report from globally recognized laboratory, CEcert GmbH, based in Germany (“CEcert”), for its Breath Logix autonomous wall mounted alcohol breathalyzer device (Figure 1). The certification is a prerequisite for the Company’s Australian distributor and opens the pathway for marketing and sales of devices in other jurisdictions. The Breath Logix product, which has several innovative features, is targeted to employers,...

Continue reading

Gentex Announces Fourth Quarter 2024 Cash Dividend

ZEELAND, Mich., Nov. 26, 2024 (GLOBE NEWSWIRE) — Gentex Corporation (NASDAQ: GNTX), the Zeeland, Michigan-based supplier of digital vision, connected car, dimmable glass, and fire protection technologies, today announced that its Board of Directors recently declared a quarterly cash dividend of $0.12 (12 cents) per share that will be payable January 22, 2025, to shareholders of record of the common stock at the close of business on January 8, 2025. About the CompanyFounded in 1974, Gentex Corporation (The NASDAQ Global Select Market: GNTX) is a supplier of automatic-dimming rearview mirrors and electronics to the automotive industry, dimmable aircraft windows for aviation markets, and fire protection products to the fire protection market. Visit the Company’s websites at www.gentex.com, fulldisplaymirror.com, and ir.gentex.com. Contact...

Continue reading

Abercrombie & Fitch Co. Reports Third Quarter Fiscal 2024 Results

Record third quarter net sales of $1.2 billion, up 14% from last year with comparable sales of 16% Broad-based net sales growth across regions and brands, with Abercrombie brands growth of 15% and Hollister brands growth of 14% Operating margin expands 170 basis points to 14.8%, with third quarter operating income increasing 30% to $179 million Year-to-date, repurchased 924,000 shares for $130 million, representing 1.8% of shares outstanding at February 3, 2024 Increases full year outlook to net sales growth of 14% to 15% and operating margin around 15%NEW ALBANY, Ohio, Nov. 26, 2024 (GLOBE NEWSWIRE) — Abercrombie & Fitch Co. (NYSE: ANF) today announced results for the third quarter ended November 2, 2024. These compare to results for the third quarter ended October 28, 2023. Descriptions of the use of non-GAAP financial...

Continue reading

Purpose Investments Inc. Announces Final November 2024 Distribution Rate for Purpose High Interest Savings Fund, Purpose US Cash Fund, Purpose Cash Management Fund, and Purpose USD Cash Management Fund

TORONTO, Nov. 26, 2024 (GLOBE NEWSWIRE) — Purpose Investments Inc. announced today the final November 2024 distribution rates for Purpose High Interest Savings Fund, Purpose US Cash Fund, Purpose Cash Management Fund, and Purpose USD Cash Management Fund. The following table reflects the final distribution amounts for the month of November. Ex-distribution date is November 27, 2024.Open-End Fund TickerSymbol Final distributionper unit Record Date Payable Date DistributionFrequencyPurpose USD CashManagement Fund –ETF Units MNU.U US $ 0.3833 11/27/2024 12/03/2024 MonthlyPurpose CashManagement Fund –ETF Units MNY $ 0.3214 11/27/2024 12/03/2024 MonthlyPurpose High InterestSavings Fund – ETFUnits PSA $ 0.1458 11/27/2024 12/03/2024 MonthlyPurpose US Cash Fund– ETF Units PSU.U US $ 0.3600 11/27/2024 12/03/2024 MonthlyAbout...

Continue reading

SpringWorks Therapeutics to Participate in the 7th Annual Evercore ISI HealthCONx Conference

STAMFORD, Conn., Nov. 26, 2024 (GLOBE NEWSWIRE) — SpringWorks Therapeutics, Inc. (Nasdaq: SWTX), a commercial-stage biopharmaceutical company focused on severe rare diseases and cancer, today announced that management will participate in a fireside chat at the 7th Annual Evercore ISI HealthCONx Conference, taking place in Coral Gables, Florida on Tuesday, December 3, 2024 at 12:30 p.m. ET. To access the live webcast, please visit the Events & Presentations page within the Investors & Media section of the company’s website at https://ir.springworkstx.com. A replay of the webcast will be available on SpringWorks’ website for a limited time following the conference. About SpringWorks Therapeutics SpringWorks is a commercial-stage biopharmaceutical company applying a precision medicine approach to developing and delivering...

Continue reading

NextCure to Participate in the 36th Annual Piper Sandler Healthcare Conference

BELTSVILLE, Md., Nov. 26, 2024 (GLOBE NEWSWIRE) — NextCure, Inc. (Nasdaq: NXTC), a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class and best-in-class therapies to treat cancer, today announced that it will participate in a fireside chat at the 36th Annual Piper Sandler Healthcare Conference in New York City on Thursday, December 5, at 12:00 pm ET. A live audio webcast will be available through the Investors section of the company’s website at www.nextcure.com. A replay of the webcast will be available after the event and archived on the website for 30 days. About NextCure, Inc.NextCure is a clinical-stage biopharmaceutical company that is focused on advancing innovative medicines that treat cancer patients that do not respond to, or have disease progression on, current therapies,...

Continue reading

Air Freight Market is Poised to Achieve Worth of USD 162.39 Billion by 2031 | SkyQuest Technology

Westford USA, Nov. 26, 2024 (GLOBE NEWSWIRE) — SkyQuest projects that the Air Freight Market size will attain a value of USD 162.39 Billion by 2031, with a CAGR of 10.3% over the forecast period (2024-2031). A combination of factors has driven rapid expansion in the air freight market in recent times. With the growth of the e-commerce industry, rapid and cross-border shipments have been emerging as a high-demand area. Air freight has become a source of critical supply chain destination due to the rapidly rising expectations of customers who seek expedited deliveries. Moreover, technological development has swept through changes in the air freight market. It interlinks blockchain, AI, and IoT to achieve better security, operation optimization, and visibility of the supply chain. All these technologies enable speedy customs processing...

Continue reading

MediWound Reports Third Quarter 2024 Financial Results and Provides Company Update

EscharEx IND Submission by Year-End; Phase 3 Study to Begin Shortly Thereafter; KOL Event Set for January 8, 2025 FDA Approves NexoBrid for Pediatric Use $25 Million Financing and €16.25 Million EIC Funding Strengthen Cash Runway to Profitability NexoBrid Product Revenue Meets Expectations; Demand Exceeds Capacity as New Manufacturing Facility Commissioning Underway Conference Call Today, November 26 at 8:30 a.m. Eastern Time YAVNE, Israel, Nov. 26, 2024 (GLOBE NEWSWIRE) — MediWound Ltd. (Nasdaq: MDWD), a global leader in next-generation enzymatic therapeutics for tissue repair, today announced financial results for the third quarter ended September 30, 2024, and provided a corporate update. “We made great headway toward our objectives this quarter, achieving a major milestone with NexoBrid approval for pediatric use in the U.S.,”...

Continue reading

The Joint Corp. to Participate in the 13th Annual ROTH Deer Valley Event

SCOTTSDALE, Ariz., Nov. 26, 2024 (GLOBE NEWSWIRE) — The Joint Corp. (NASDAQ: JYNT), a national operator, manager, and franchisor of chiropractic clinics, announced that management is scheduled to attend the 13th Annual ROTH Deer Valley Event on December 11-14, 2024. The conference is being held at the Montage Deer Valley in Park City, UT. President and Chief Executive Officer Sanjiv Razdan and Chief Financial Officer Jake Singleton will host one-on-one meetings on December 12th and 13th. Interested investors should contact their ROTH representative or Kirsten Chapman of Alliance Advisors IR at thejointinvestor@allianceadvisors.com. About The Joint Corp. (NASDAQ: JYNT)The Joint Corp. (NASDAQ: JYNT) revolutionized access to chiropractic care when it introduced its retail healthcare business model in 2010. Today, it is the nation’s...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.